+ All Categories

NEW B.P

Date post: 24-Oct-2014
Category:
Upload: aqifawaris
View: 81 times
Download: 7 times
Share this document with a friend
Popular Tags:
52
Acknowledgements This is the official report of Jawa Pharmaceuticals (pvt) limited. We hope it will soon be very helpful for you. Our sincere thanks to professor Ghulam Ahmed Rana for giving us a chance to work in a group where we were able to polish our communication, presentation and all kind of creative skills. Special thanks to Agha Asghar for providing references and Muhammad BaqirJawa (Managing director of Pharmaceuticals) without them we could not have been visit factory where most of our research was completed and many of our surveys were conducted. We would like to thank our parents and family members as well because they provided us the financial and moral support in doing this project. And last of all whatever we have done, it is just because of the coordination and cooperation of all the members of the group. All had worked hard for collecting the data and performing surveys. 1 | Page
Transcript
Page 1: NEW B.P

Acknowledgements

This is the official report of Jawa Pharmaceuticals (pvt) limited. We hope it will soon be

very helpful for you. Our sincere thanks to professor Ghulam Ahmed Rana for giving us a

chance to work in a group where we were able to polish our communication, presentation

and all kind of creative skills. Special thanks to Agha Asghar for providing references and

Muhammad BaqirJawa (Managing director of Pharmaceuticals) without them we could not

have been visit factory where most of our research was completed and many of our surveys

were conducted.

We would like to thank our parents and family members as well because they provided us

the financial and moral support in doing this project. And last of all whatever we have done,

it is just because of the coordination and cooperation of all the members of the group. All

had worked hard for collecting the data and performing surveys.

Table of ContentsINTRODUCTION......................................................................................................................................................... 8

BRIEF HISTORY.......................................................................................................................................................... 9

SITUATIONAL ANALYSIS.....................................................................................................................................12

STRUCTURE OF THE ORGANIZATION...........................................................................................................13

ORGANIZATION STRUCTER.......................................................................................................................... 14

LOCATION:................................................................................................................................................................. 15

1 | P a g e

Page 2: NEW B.P

KEY PLAYERS............................................................................................................................................................ 16

Number of total employee.................................................................................................................................. 16

MISSION STATEMENT.......................................................................................................................................... 17

Vision............................................................................................................................................................................ 17

GOALS AND OBJECTIVES..................................................................................................................................... 18

O B J E C T I V E S ................................................................................................................................................. 18

EXTERNAL AND INTERNAL ASSESMENT....................................................................................................19

EFE Matrix.................................................................................................................................................................. 23

IFE Matrix................................................................................................................................................................... 24

CPM............................................................................................................................................................................... 25

SWOT MATRIX......................................................................................................................................................... 26

Space Matrix for Millat tractor..........................................................................................................................27

BCG MATRIX.............................................................................................................................................................. 29

IE Matrix...................................................................................................................................................................... 30

GRAND STRATEGY:................................................................................................................................................ 31

Core Competencies and Key Success Factors:............................................................................................32

CORPORATE CULTURE.........................................................................................................................................33

Strategies undertaken at the:............................................................................................................................ 35

HR Department of Millat Tractors...................................................................................................................36

Main functions of HR department in Millat Tractors Limited........................................................37

Performance Evaluation:..................................................................................................................................... 38

Labour laws of Islamic Republic of Pakistan and those practiced in Millat Tractors Limited......................................................................................................................................................................................... 38

Labour Rights in the Constitution...........................................................................................................38

Termination of the Contract.......................................................................................................................... 39

Paid Leave and Other Leave Entitlements:.........................................................................................40

Equality:.................................................................................................................................................................. 41

Freedom of association:.............................................................................................................................. 42

Registration of unions:................................................................................................................................ 42

ADMINSITRATION STRATEGIES......................................................................................................................44

DECISION MAKING................................................................................................................................................. 44

TOTAL QUALITY MANAGEMENT.................................................................................................................... 45

Compensation and Benefits:.............................................................................................................................. 46

Workers Concession Shop:................................................................................................................................. 47

Workers concession shop where flour, ghee, sugar, soap, etc is provided only to the workers at subsidized rate................................................................................................................................. 47

2 | P a g e

Page 3: NEW B.P

Market Analysis....................................................................................................................................................... 48

Segments and Target Market........................................................................................................................ 48

Products:................................................................................................................................................................ 48

Price:........................................................................................................................................................................ 51

Placement:............................................................................................................................................................. 51

Promotions:........................................................................................................................................................... 53

Political:.................................................................................................................................................................. 53

Market Share:............................................................................................................................................................ 54

Market Position........................................................................................................................................................ 55

USP................................................................................................................................................................................. 57

USP of Millat Tractors Limited:.................................................................................................................... 57

Competitive Analysis:............................................................................................................................................58

FINANCIAL STRATEGISE.....................................................................................................................................59

OTHER STRATEGIES..............................................................................................................................................61

Research and Development........................................................................................................................... 61

Production:............................................................................................................................................................ 63

CONTROL PROCEDURES..................................................................................................................................... 64

Marketing control...............................................................................................................................................64

PRODUCTIN CONTROL.................................................................................................................................... 65

QUALITY CONTROL........................................................................................................................................... 66

FINANCE CONTROL:......................................................................................................................................... 66

HRM CONTROL:................................................................................................................................................... 67

PROBLEM SECTION............................................................................................................................................... 69

3 | P a g e

Page 4: NEW B.P

COMPANY PROFILE

Name : Jawa Pharmaceutical

Logo :

Established in : 1967

Industry : Pharmaceuticals Industry

Business Based : Private Company

Type of Ownership : Corporation.

Location : 112/10 Quaid-e-Azam industrial area, KotLakhpat,

Lahore, Pakistan

Brief history

Ambition to get success is a driving force for any noble aim. No ambition can germinate

without seed of commitment and light of consistent effort. By grace of God, the immense

4 | P a g e

Page 5: NEW B.P

contribution of Jawa Pharmaceuticals towards the health care of the masses is an

unprecedented glittering mark of strenuous effort and consolidated strategies.

          Jawa Pharmaceuticals was established with the objective of developing medicines to

cure suffering humanity. Its main concern was to earn idea-breeding minds by grasping the

finger of progress in the field of science and research.

          For the first time, company was licensed in 1967 when it was located in Samanabad

then with the passage of time; we felt the need of extension, so the company was shifted to

Garden Town in 1972, then finally to KotLakphat in 1982.

          As Jawa Pharmaceuticals has always been typing to stare in the eyes of time

challenges.

          Therefore, in 2005, by visualizing our continuous commitment with quality, we got

accreditation of ISO 9001-2000. This reveals we have a solid control on our processes and

drugs. The company is well aware of the international standard and its demand. Due to

diversified planning and concrete action, all departments are well equipped with state of

art machinery and modern functioning. System, especially the quality department stands a

few inches above others regarding technology and expertise.

Organizational Hierarchy

5 | P a g e

Page 6: NEW B.P

Location of office

JawaPharmaceuticals (pvt) Ltd.

112/10 Quaid-e-Azam industrial area, KotLakhpat, Lahore, Pakistan

6 | P a g e

C.E.O

Management Director

Marketing

Department

Marketing NSM

Export

Manager

Procurement

Manager

HR Manag

er

Assistant

Finance Department

M.I.S

Production Director

Plant Manager

Page 7: NEW B.P

Nature of business

It is a Private limited company.

Total no of employees:

Jawa pharmaceutical have approx. 280 employees which includes management authorities,

department heads, Supervisors, Assistants and all the functional level employees

Key players:

Mission & Vision statement

7 | P a g e

Jawa Pharmaceuticals (pvt) Limited.

Raza Jawa

Baqir Ali jawa

Sajid Ali jawa

Page 8: NEW B.P

Vision Statement

“Commitment to save humanity”

Mission Statement

“Committed to manufacture quality products to satisfy our customers by

efficient utilization and development of all our resources”

Suggested Mission Statement

“Committed to manufacture quality products to ensure the health of our

customer around the world by effective utilization and development of

all our human and technological resources”

Goal & objective;

Objectives:

8 | P a g e

Page 9: NEW B.P

To achieving its exporting goal Jawa pharmaceuticals would be providing its

products to Sri-lanka, Philippine.

Provide corporate sales growth with a sufficient rate annually with a significant

increase in per-person productivity level without compromising profitability.

Organization development its own online portal to attain efficiency.

Introduction of more products in diversified range includes

Dermatological products

Cephalosporins.

Quinolones and macrolides to attain more classes of customers.

Goals:

Expanding business through enhancing product lane.

Jawa pharmaceuticals will enhance its business through market development

strategy (Exporting).

Improvement in Financial planning & efficiency of others systems by effectively

utilizing the I.T. backbone.

Enhancement of production capacity according to the future growth plans to meet

the sales growth.

External and internal assessment

Company: Jawa Pharmaceuticals pvt Ltd.

PESTLE:

9 | P a g e

Page 10: NEW B.P

PESTLE analysis stands for "Political, Economic, Social, Technological, Legal and

Environmental analysis" and help organizations making STRATEGIES by helping them to

understand the external environment in which the companies operate the functions.

PESTLE analysis of Jawa Pharmaceuticals Pvt Ltd.

Political:

When we talk about any Pharmaceuticals company in the context of PESLE analysis,

we came to know that these companies have not any direct impact of political condition.

Economical:

Economical condition has a greater influence on Pharmaceutical companies, because

in Un-stable economical condition like Inflection or recession situation the company has to

change its strategies. The strategies align according to the Economical situation of country.

Social:

Social condition also have its direct impact on Jawa Pharmaceuticals, like in the situation of

War all the foreign companies will shut down there operations and it’s time for the locals

companies to support their nation. As the other firms shut off the production of the local

companies would increase to meet the requirement of consumers.

Technology:

It is also an important factor that influence on JAWA pharmaceuticals, because now

a days there is a rapid growth in the technology a lot of innovations and advancement is

10 | P a g e

Page 11: NEW B.P

there in the machineries that enhance the firm`s production, reduce time and give better

quality, so to compete with other firms you also have to better your system.

Legal:

The government and the legal authorities has greater impact on the pharma

industry. The more important factor that has a greater influence on Pharmaceuticals

companies, like Quality control, environmental control authorities etc.

Environmental:

Environment has also its effects on pharmaceutical company and as well to its

product which cause increase in the products sale and on the other hand to shut off the

organization. Like: recently the flood and Dengue virus in Pakistan boosted the sale of

medicines.

MIKLEPORTER’S FIVE MODELS

Mikleporter provides a frame work that an industry is influence by these forces:

1. Rivalry:

Pharma industry is one of the most competitive industries in the country with as many

11 | P a g e

Page 12: NEW B.P

different rivals’ fights for selling the same product with different names. At this stage

the JAWA Pharmaceutical has four major competitors that are the local competitors:-

IrzaPharma

Unexo Laboratories

MunwarPharma

Drug Pharma

2. Bargaining power of Customers:

The unique feature of Pharma industry is that the end user is very important who buys the

product. The consumer has a greater choice to buy the same product from other

manufacturer. However, when we look at the buyer's power, we look at the influence they

have on the prices of the product. Government with its policies plays an important role in

regulating pricing through the NPPA (National Pharmaceutical Pricing Authority).

In the JAWA pharmaceutical the product is sold by the two ways:-

Over the Counter Sales (OTC)

Sales Representative

3.Bargaining power of Suppliers:

The Pharma industry depends upon several organic chemicals. The chemical industry is

again very competitive and fragmented. The chemicals used in the Pharma industry are

12 | P a g e

Page 13: NEW B.P

largely a commodity. Because of the economical changes in the country the prices of the

raw material is increasing very rapidly which cause the high rate of the raw materials.

The active materials are also imported from China and India which cost the company at the

competitive rates.

4.Threat of substitutes:

The biggest threat to the pharmaceutical industry is the substitute products which are been

developed by the competitors and are named differently having the same chemical

composition. Therefore the companies which enter newly in the Pharma business they

develop the products at the less prices causing the customer turn towards their products.

The substitute herbal products are causing the great threat to the JAWA Pharma, like the

cough controlling syrup made herbally by the Quershi is damaging the market share of the

JAWA cough control syrup.

5.Potential entry of new Competitors:

It is not only incumbent rivals that pose a threat to firms in an industry; the possibility that

new firms may enter the industry also affects competition. Industries possess

characteristics that protect the high profit levels of firms in the market and inhibit

additional rivals from entering the market. The new entrant should have to get the legal

orders from the Government to make any product and for registering the firm. High growth

prospects make it attractive for new players to enter in the industry. The industry

attractiveness is low.

EFE MATRIX

13 | P a g e

Page 14: NEW B.P

Opportunities Weight Rating Weighted score

1. Export 0.10 3 .30

2. Regulated Market .07 2 .14

3. Enhance product Lane .10 3 .30

4. Related diversification .08 3 .24

5. Environmental changes .07 2 .14

Threats

1. Bargaining Power of Supplier .12 3 .36

2. Bargaining power of Customer .09 3 .27

3. Customer loyalty .09 3 .27

4. High Competition .10 4 .40

5. Time issues .08 3 .24

6. License Procedures .10 3 .30

1 2.96

IFE MATRIX

14 | P a g e

Page 15: NEW B.P

Strength Weight Rating Weighted score

1. Technological Advancement .13 4 .52

2. Quality Certificates (ISO) .10 4 .40

3. Business Growth .09 3 .27

4. M.I.S. .08 3 .24

5. Research & Development .11 3 .33

Weakness

6. Centralized System .12 1 .12

7. Employee Moral .10 1 .10

8. Time Utilization .08 2 .16

9. Trained Staff .10 2 .20

10.Loyalty in Worker .08 2 .16

1 2.50

15 | P a g e

Page 16: NEW B.P

C.P.M

JawaPharm

a

IrzaPharma DrudPharma

Critical

success factor

Weight Rate Score Rate Score Rate Score

Advertising .16 2 .32 2 .32 2 .32

Customer

loyalty

.18 2 .36 2 .36 1 .18

Management .13 3 .39 3 .39 2 .26

Export .16 3 .48 2 .32 1 .16

Market share .17 3 .51 3 .51 2 .34

Product Quality .20 4 .80 3 .60 3 .60

Space matrix16 | P a g e

Page 17: NEW B.P

Internal strategic position Score External strategic position Score

Financial strength (FS) Environmental stability (ES)

1:Return on investment 3 1:Rate of inflation -3

2:Leverage 2 2:Demand Variability -4

3:Liquidty 2 3:Price range of competing

products

-2

4:working capital 6 4:Barriers to entry -1

5:Cash flow 4 5:Competitive pressure -2

6:Inventory turnover 4 6:Easy to exit -3

7:Earning per share 3 7:Price elastic of demand -2

8:Price earnings ratio 3 8:Risk involved in business -4

9: Technological changes -2

Average score 3.375 Average score -2.55

Competitive advantage (CA) Industry Strength (IS)

1:Market share -4 1:Growth potential 5

2:Product quality -3 2:profit potential 4

3:Product life cycle -3 3: Financial stability 4

4:Customer loyalty -6 4:Resource utilization 3

5:Competation capacity -4 5:Ease of entry into market 1

6:Contorl over suppliers &

distributer

-3 6:Productivity, capacity,

utilization

3

7: Technological know how -3 7: Technical know how 5

Average score -3.71 Average score 3.57

17 | P a g e

Page 18: NEW B.P

Internal factors

External factors

Strengths

Technological advancement

Quality Certificate (ISO)

Business growth M.I.S Research &

development

Weaknesses

Centralized system Lack of Loyalty in

worker. Time utilization. Lack of trained staff. Employee morale

Opportunities

Export Enhanced product

lane Related

diversification Environmental

changes

(S.O) Strategies

Updating machinery for enhancing product lane.

Certification for quality production.

(W.O) Strategies

Trained employees should be hired for export.

Loyalty in employees of enhancing product lane

Threats

Barging power of suppliers

Barging power of customer

Lack of customer loyalty

High competition Time issues Licensed

procedures

(S.T) Strategies

Business growth by using backward integration.

Quality certification for gaining customer loyalty.

Better M.I.S for solving time issues.

(W. T) Strategies

Hiring of Trained staff for increasing sales and manufacturing.

Time should be minimized for gaining licenses.

18 | P a g e

S.W.O.T

Page 19: NEW B.P

POSITION IN BOSTAN CONSULTING GROUP

(BCG) MATRIX

The position of our product in the BCG matrix can be identified on the basis of following

facts regarding our product:

Industry growth rate is very high

low market share is there for the product

Higher Market share could easily be achievable in future.

Grand Strategy Matrix19 | P a g e

Anti-anemic

Antibacterial & Analgesics Antacid & multi-vitamins

Cold, Cough & External prep.

Page 20: NEW B.P

IE matrix:

Core Competency Analysis

20 | P a g e

Rapid Market Growth

Low Market Growth

Strong Competitive Position

Weak Competitive Position

Quad-II Quad-I

Quad-III Quad-IV

Page 21: NEW B.P

The core competency of Jawa pharmaceuticals is its R & D Department which moves on

innovating and discovering the new product for the health of people. Jawa have very hard

working employees in R & D department which is considered as a backbone for the

company. Jawa does not compromise the quality on profitability and search on for the

better tomorrow. That`s why they say that we are dedicated to provide quality medicine

and having the ISO 9001:2000 certified organization we follow standard operating

procedures with a defined quality policy.

Corporate Culture:

Jawa pharmaceuticals is using the traditional corporate culture with in the management

efficiency, the strong reasons to use the traditional culture is due to practicing the

centralized decision making system. The organization is having the weak culture because

there are no shared values and beliefs. Employee works according to the values and

traditions owner. The department heads are responsible for their domain and there are

no group meetings.

Strategies under taken at:

Corporate level:

At the corporate level all the corporate level strategies are been made by the

key players of the company. Such as the organization is being using market development,

product development and related diversification.

Business level:

At the business level the heads of departments make strategies accordings to

the rules of the organization with the concent of key players and that strategies are

alligned wuth the corprate level strategies.

Fuctional level:

21 | P a g e

Page 22: NEW B.P

At the functional level the strategies are given by the departments supervisiors and

every one is responsible for their own work. The supervisior are accountable to the

management.

Management strategies

Adminstration department:

The administration department has 3 assistance it also includes the mintance head

and security persons . Due to the small firm and the weak organizational culture all the

adminstration strategies are implmented and made by the management director.

Decision Making

Jawa Pharmaceuticals is practicing Centralized Decision Making all the decisions are being

made by Chief Executive Officer Sajid Ali Jawa. The organization has a Tall Structure.

Total Quality Management

Quality Control:-

We have a modern and well-equipped Quality Control (QC) Laboratory, which ensures that

our products are pure, safe and effective. Each product must pass the requisite analysis as

per stringent compendia specifications, methods and procedures developed according to

international guidelines.

The QC department performs following activities:

RM/PM analysis

Finished Products analysis

In-process Checks

Stability Studies

Quality Assurance:-

22 | P a g e

Page 23: NEW B.P

Our QC department has all necessary instruments for analysis of API, finished products,

packaging and related materials used.

Finished products are not supplied sold before authorized personnel have cert production

batch has been produced and controlled in accordance with the requirement and

conformed to the required specification and standards.

The effectiveness of the quality management system is checked at appropriate it self

inspections and audits.

All products which are sold in the market are monitored through a comprehensive

Surveillance System. In case of any complaints from the market, proper investing out to

discover the root cause of the compliant. Appropriate preventive and correct are taken

promptly in order to prevent recurrence.

Marketing AnalysisSegment & Target Market

Marketing Segmentation

We segment our market by keep in view the different factors of market.

Target Market23 | P a g e

Geographic`s Country: PakistanDencity: Urban & ruler

Demographic`s Gender:Male & femaleAge: All ages

psychographic`s Social class: Upper, Upper middle, Middle Class and lower class

Page 24: NEW B.P

Doctors, NGOs, Govt. hospitals, Private Clinics are the main target market for Jawa

Products.

4 P’s of Market Analysis

Product:-

The product lane of Jawa Pharmaceutical is as under:-

PRODUCT LIST

ANALGESICS, ANTIPYRETIC, ANTIRHEUMATIC

SR  PRODUCT NAME  GENERIC NAME DOSAGE

FORM PACKING

1  Ambrofen  Ibuprofen 100mg/5ml  Suspension  90ml

2  Ambrofen  Ibuprofen 100mg/5ml  Suspension  400ml

3  Amnic  Mefenamic Acid 50mg/5ml  Suspension  60ml 

4  Amnic  Mefenamic Acid 50mg/5ml  Suspension  450ml

5  Ambrofen  Ibuprofen 200mg  Tablets  500's

6  Ambrofen  Ibuprofen 200mg  Tablets  50X10's

7  Ambrofen  Ibuprofen 400mg  Tablets  250's

8  Ambrofen  Ibuprofen 400mg  Tablets  25X10's

9  Amnic  Mefenamic Acid250mg  Tablets  1000's

10  Amnic  Mefenamic Acid250mg  Tablets  60X10's

11  Paracetamol  Paracetamol 500mg  Tablets  1000's

12  Paracetamol  Paracetamol 500mg  Tablets  20X10's

13  Aspirin  Aspirin300mg  Tablets  1000's

24 | P a g e

Page 25: NEW B.P

14  Jfenac  Diclofenac Sodium 50mg  Tablets  2X10's

15  Jfenac-P  Diclofenac Potassium 50mg  Tablets  2X10's

16  Zebroxen  Neproxen Sodium 275mg  Tablets  3X10's

17  Zebroxen  Neproxen Sodium 550mg  Tablets  2X10's

18  Taprofen  Flurbiprofen100mg  Tablets  3X10's

19  Jcenac  Aceclofenac100mg  Tablets  1X10's

20  Joxicam  Meloxicam 7.5mg  Tablets  1X10's

21  Joxicam  Meloxicam 15mg  Tablets  1X10's

22  Paincure  Paracetamol 450mg + Orphanedrine Citrate 35mg  Tablets  10X10's

23  Paincure Fort  Paracetamol 650mg + Orphanedrine Citrate 50mg  Tablets   1X10's

ANTIHISTAMINES

1  Chlorphenramine Maleate  ChlorphenramineMeleate 2mg/5ml  Syrup  60ml

2  Chlorphenramine Maleate  ChlorphenramineMeleate 2mg/5ml  Syrup  120ml

3  Chlorphenramine Maleate  ChlorphenramineMeleate 2mg/5ml  Syrup  450ml

4  ChlorphenramineMaleate  ChlorphenramineMeleate 4mg  Tablets  1000's

5  Chlorphenramine Maleate  ChlorphenramineMeleate 4mg  Tablets  2X50's

6  Fanoxin  Fexofenadine HCl 60mg  Tablets  1X10's

7  Fanoxin  Fexofenadine HCl 120mg  Tablets  1X10's

8  Rinex  Desloratadine 5mg  Tablets  1X10's

9  M.Brozine  Promethazine HCl 5mg/5ml  Elixir  120ml

10  M.Brozine  Promethazine HCl 5mg/5ml  Elixir  450ml

11  M.Brozine  Promethazine HCl 10mg  Tablets  1000's

25 | P a g e

Page 26: NEW B.P

12  Lortab  Loratadine 10mg  Tablets  1X10's

13  Lortab  Loratadine 5mg/5ml  Syrup  30ml

14  Lortab  Loratadine 5mg/5ml  Syrup  60ml

15  Jastine  Ebastine10mg  Tablets  1X10's

16  Cetzi  Cetirizine Dihydrochloride 10mg   Tablets  1X10's

17  Cetzi  Cetirizine Dihydrochloride 5mg/5ml   Syrup  60ml

18  Lecetzi  Levocetirizine 5mg   Tablets  1X10's

19  Fenoxin-CF  Fexofenadine HCl 60mg, Pseudoephedrine HCl 120   Tablets  1X10's

ANTIBACTERIAL AND AMOEBICIDES

1  Amtril Trimethoprim 40mg, Sulphamethoxazole

200mg/5ml  Suspension  50ml

2  Amtril Trimethoprim 40mg,

Sulphamethoxazole200mg/5ml  Suspension  400ml

3  Amtril  Trimethoprim 80mg, Sulphamethoxazole 400mg  Tablets  200's

4  Amtril  Trimethoprim 80mg, Sulphamethoxazole 400mg  Tablets  20X10's

5  Amtril DS  Trimethoprim 160mg, Sulphamethoxazole 800mg  Tablets  100's

6  Amtril DS  Trimethoprim 160mg, Sulphamethoxazole 800mg  Tablets  10X10's

7  Metzol  Metronidazole 200mg  Tablets  20X10's

8  Metzol  Metronidazole 400mg  Tablets   2X10's

9  Metzol  Metronidazole 400mg  Tablets  10X10's

10  Metzol  Metronidazole Benzoate eq. to Metronidazole  Suspension  60ml

26 | P a g e

Page 27: NEW B.P

200mg/5ml

11  Mntazole  Metronidazole 200mg, Diloxanide 250mg  Tablets  3X10's

12  Mntazole - DS  Metronidazole 400mg, Diloxanide 500mg  Tablets  5X3's

13  Mntazole DiloxanideFurote

250mg ,Metronidazole(Benzoate) 200mg/5ml  Suspension  60ml

14  Jawaflox  Ciprofloxacin (HCl) 250mg  Tablets  1X10's

15  Jawaflox  Ciprofloxacin (HCl) 500mg  Tablets  1X10's

16  Joxacin  Ofloxacin 200mg  Tablets  1X10's

17  Jevelexin  Levofloxacin 250mg  Tablets  1X10's

18  Jevelexin  Levofloxacin 500mg  Tablets  1X10's

19  Jnor  Norfloxacin 400mg  Tablets  2X7's

20  Jawaclar  Clarithromycin 250mg  Tablets  1X10's

21  Jawaclar  Clarithromycin 500mg  Tablets  1X10's

22  P-Lock  PefloxacinMesylate 400mg  Tablets  1X10's

23  J-Rox  Roxithromycin 150mg  Tablets  1X10's

24  Typdex  Nalidixic Acid 500mg  Tablets  3X10's

25  Xyrox  Erythromycin Stearate eq.to Erythromycin 250mg  Tablets  10's

26  Xyrox  Erythromycin Stearate eq.to Erythromycin 500mg  Tablets  10's

27  Mox-Q  Moxifloxacin 400mg  Tablets  1X5's

28  Bactocare  Azithromycin Dihydrate 200mg/5ml  Suspension  15ml

29  Bactocare  Azithromycin Dihydrate 250mg  Capsules  1X10's

30  Jawaclar  Clarithromycin 125mg/5ml  Suspension  60ml

31  Jalidix  Nalidixic Acid 250mg/5ml  Suspension  60ml

27 | P a g e

Page 28: NEW B.P

32  Xyrox  Erthromycin Ethyl Succinte 200mg/5ml  Suspension  60ml

33  Darphin  Cephradine (as Monohydrate) 250mg  Capsules  1X12's

34  Darphin  Cephradine (as Monohydrate) 500mg  Capsule  1x12's

35  Darphin  Cephradine (as Monohydrate) 125mg  Suspension  60ml

36  Darphin  Cephradine (as Monohydrate) 250mg  Suspension  60ml

37  Zixim  Cefixime (as Trihydrate) 100mg  Suspension  30ml

38  Zixim  Cefixime (as Trihydrate) 400mg  Capsule  1x5's

39  Zclor  Cefaclor (As monohydrate) 125mg  Suspension  60ml

40  Zclor  Cefaclor (As monohydrate) 250mg  Suspension  60ml

41  Xeclor  Cefaclor (As monohydrate) 250mg  Capsule  1x12's

42  Jafotax  Cefotaxime 250mg  Injection  1 Vial

43  Jafotax  Cefotaxime 1gm  Injection  1 Vial

44  Darphin  Cepharadine 500mg  Injection  1 Vial

45  Fopera  Cefoperazone 1gm, Sulbactum 1gm  Injection  1 Vial

46  Fopera  Cefoperazone 0.5gm, Sulbactum 0.5gm  Injection  1 Vial

47  T-Zd  Ceftazidime 250mg  Injection  1 Vial

48  T-Zd  Ceftazidime 1gm  Injection  1 Vial

49  Jewpime  Cefepime 500mg, Sterile Arginine 250mg  Injection  1 Vial

50  Jewpime  Cefepime 1gm, Sterile Arginine 500mg  Injection  1 Vial

51  Try-x  Ceftriaxone 250mg  Injection  1 Vial

52  Try-x  Ceftriaxone 1gm  Injection  1 Vial

ANTACID, ANTIFLATULENTS & ANTIULCER

28 | P a g e

Page 29: NEW B.P

1  Carminative Mixture

 “Sod. Bicarbonate 5g, SpiritammoniaAromat 6.5ml,

 Tr. Cardco 6.5ml, Aqua Mentha Pip Conc.

4.8ml/100ml"

 Mixture  120ml

2  Carminative Mixture

 “Sod. Bicarbonate 5g, SpiritammoniaAromat 6.5ml,

 Tr. Cardco 6.5ml, Aqua Mentha Pip Conc.

4.8ml/100ml"

 Mixture  450ml

3  Mebrosil Mag. Trisilicate 500mg, Aluminium Hydroxide

250mg  Tablets  500's

4  Mebrosil Mag. Trisilicate 500mg, Aluminium Hydroxide

250mg  Tablets  50x10's

5  Soda Mint  Sodium Bicorbonate 300mg  Tablets  1000's

6  Amtri  Mag. Trisilicate 500mg  Tablets  1000's

7  Amtri  Mag. Trisilicate 500mg  Tablets  50x10's

8  Rantab  Ranitidine 150mg  Tablets  1x10's

9  Stomachcare  Famotidine 20mg  Tablets  2x10's

10  Stomachcare  Famotidine 40mg  Tablets  1x10's

11  Stomachcare  Famotidine 10mg/5ml  Suspension  60ml

12  Pentazole  Pantoprazole 40mg  Tablets  14's

13  R-bzole  Rabeprazole Sodium 10mg  Tablets  1x10's

14  R-bzole  Rabeprazole Sodium 20mg  Tablets  1x14's

15  Mebrazole  Omeprazole 20mg  Capsules  2x7's

16  Laprole  Lansoprazole 30mg  Capsules  2x7's

29 | P a g e

Page 30: NEW B.P

17  Ulcicare  Esomeprazole 20mg  Capsules  2x7's

18  Ulcicare  Esomeprazole 40mg  Capsules  2x7's

ANTI-ANAEMIC PREPARATIONS

1   Ferrous Sulphate  Ferrous Sulphate 200mg/5ml  Syrup  120ml

2  Ferrous Gluconate  Ferrous Gluconate 300mg/5ml  Syrup  120ml

3  Fertogen Iron Polymaltose Complex eq. to Elemental Iron

50mg/5ml  Syrup  60ml

4  Fertogen Iron Polymaltose Complex eq. to Elemental Iron

100mg  Tablets  1x10's

5  Fertogen-F  Iron Polymaltose Complex eq. to

 Elemental Iron 100mg+Folic Acid 0.35mg  Tablets  1x10's

6  Hemo-GB Iron Proteinsuccinylate 800mg, Elemental Iron

40mg/15ml Syrup  60ml

ANTHELMINTICS

1  Piperazine  Piperazine Citrate eq. to Piprazine Hydrate 750mg  Elixir  30ml

2  Piperazine  Piperazine Citrate eq. to Piprazine Hydrate 750mg  Elixir  450ml

3  Jenzole  Albendazole 200mg/5ml  Suspension  10ml

4  Jenzole  Albendazole 200mg  Tablets  2's

5  Jenzole  Albendazole 200mg  Tablets  1x10's

6  Zenzol  Mebendazole 100mg  Tablets  6x10

7  Zenzol  Mebendazole 100mg/5ml  Suspension  30ml

ANTIMALARIALS

1  Chloroquine Phosphate  Chloroquine Phosphate eq. to Chloroquine Base  Syrup  60ml

30 | P a g e

Page 31: NEW B.P

50mg/5ml

2  Chloroquine Phosphate  Chloroquine Phosphate eq. To Chloroquine Base

50mg/5ml  Syrup  4500ml

3  Chloroquine Phosphate  Chloroquine Phosphate 80mg  Tablets  1000's

4  Amfan  Lumefantrine 120mg, Artemether 20mg  Tablets  1x16's

5  Haptoval  Sulfadoxine 500mg, Pyrimethamine 25mg  Tablets  1x10's

6  Zydar  Sulfadoxine 500mg, Pyrimethamine 25mg  Syrup  15ml

BRONCHODILATORS

1  Theophylline  Theophylline Sod. Glycinate 150mg  Syrup  60ml

2  Theophylline  Theophylline Sod. Glycinate 150mg  Syrup  450ml

3  Aminophylline  Aminophylline 100mg  Tablets  1000's

4  Astamol  Salbutamol 2mg/5ml  Syrup  60ml

5  Amacure  Montelukast sodium 5mg  Tablets  14's

6  Amacure  Montelukast sodium 10mg  Tablets  14's

CARDIOVASCULAR PREPARATIONS (ANTI HYPERTENSIVE)

1  Cardiocare  Amlodipine Besylate eq. to Amlodipine 5mg  Tablets  2x10's

2  Cardiocare  Amlodipine Besylate eq. to Amlodipine 10mg  Tablets  2x10's

3  Cardat  Atenolol 50mg  Tablets  2x10's

4  Cardat  Atenolol 100mg  Tablets  2x10's

5  Jasartan  Losartan Potassium 50mg  Tablets  2x10's

6  Japril  EnalaprilMeleate 5mg  Tablets  2x10's

7  Japril  EnalaprilMeleate 10mg  Tablets  2x10's

COLD & COUGH PREPARATIONS

31 | P a g e

Page 32: NEW B.P

1  Amrid "Ammonium Chloride 100mg, Chlorphenramine

  Maleate 2mg, Ephedrine HCl 7mg/5ml"  Syrup  60ml

2  Amrid "Ammonium Chloride 100mg, Chlorphenramine

  Maleate 2mg, Ephedrine HCl 7mg/5ml"  Syrup  120ml

3  Amrid "Ammonium Chloride 100mg, Chlorphenramine

  Maleate 2mg, Ephedrine HCl 7mg/5ml"  Syrup  450ml

4  M.Brophylline “Aminophylline 32mg, Diphenhydramine 8mg,

  Ammonium Chloride 30mg/5ml"  Syrup  120ml

5  M.Brophylline "Aminophylline 32mg, Diphenhydramine 8mg,

  Ammonium Chloride 30mg/5ml"  Syrup  450ml

6  Mephen Diphenhydramine HCl 13.5mg,

 Ammonium Chloride 131.5mg/5ml  Syrup  120ml

7  Mephen Diphenhydramine HCl 13.5mg,

 Ammonium Chloride 131.5mg/5ml  Syrup  450ml

8  Ambrofen P  Ibuprofen 200mg, Pseudoephedrine HCl 300mg  Tablets  10x10's

9  Ambrofen-P Fort  Ibuprofen 400mg, Pseudoephedrine HCl 60mg  Tablets  10x10's

10  Ambrofen-P  Ibuprofen 100mg, Pseudoephedrine HCl 15mg  Suspension  60ml

11  Flutabs Paracetamol 500mg, PesudoephedrineHCl 60mg,

 Chlorpheniramine 4mg Tablets  10x10's

EXTERNAL PREPARAION

1  Iodine  Iodine 4%, Methyl Salicyclate 5%  Oinment  10x25gm

2  M. Broplast  “Kaolin Heavy 52.7g, Boric Acid 4.5g, Thymol  Oinment  100mg

32 | P a g e

Page 33: NEW B.P

0.05g,

   Methyl Salicylate 0.2ml, Peppermint Oil 0.05ml,

   Glycerin 10g Propylone Glycol 32.5g/100gm"

3   Calamina Lotion  Calamine 15gm, Zinc Oxide 5g/100ml  Lotion  120ml

4   Tr. Benzonic Co.  Benzoin 100gm, Aloe 20gm, Storex 80gm/100ml  Tincture  10x25ml

5   Tr. Benzonic Co.  Benzoin 100gm, Aloe 20gm, Storex 80gm/100ml  Tincture  400ml

6   Tr. Iodine  Mitis Iodine 2%  Tincture  10x25ml

7   Tr. Iodine  Mitis Iodine 2%  Tincture  400ml

ELECTROLYTE

1  Amural  Sod. Acid Citrate 1.25gm/5ml  Syrup  120ml

2  Amural  Sod. Acid Citrate 1.25gm/5ml  Syrup  450ml

LAXATIVES

1  Jalac  Lactoluse 67gm/100ml  Syrup  120ml

MULTIVITAMINS, CALCIUM PREPARATION

1  M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,

 Pyridoxine 2mg, Nicotinamide 23mg/15ml  Syrup  60ml

2  M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,

 Pyridoxine 2mg, Nicotinamide 23mg/15ml  Syrup  120ml

3  M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,

 Pyridoxine 2mg, Nicotinamide 23mg/15ml  Syrup  450ml

4  M. Broplex Thiamine HCl 1mg, Riboflavin 1mg,

 Nicotinamide 15mg/tablet  Tablets  1000's

5  M. Broplex  Thiamine HCl 1mg, Riboflavin 1mg,  Tablets  2x50's

33 | P a g e

Page 34: NEW B.P

 Nicotinamide 15mg/tablet

6  Mcobal  Mecobalamine 500 g  Tablets  2x10's

7  Cal-P  Vitamin D 350IU, Calcium Phosphate (Tribasic)

210mg/5ml  Syrup  120ml

8  Calchew-D  Calcium Carbonate 1250mg, Vitamin D 125IU  Tablets  30’s

9   M. Brovit

 "Vit. A 2500 IU, Vit. D 250 IU Ascorbic Acid 15mg

Thiamine

   HCL 0.55mg, Riboflavin 0.65mg, Nicotinamide

5.5mg/5ml"

 Syrup  60ml

10   M. Brovit

 "Vit. A 2500 IU, Vit. D 250 IU Ascorbic Acid 15mg

Thiamine

   HCL 0.55mg, Riboflavin 0.65mg, Nicotinamide

5.5mg/5ml"

 Syrup  120ml

ORAL HYPOGLYCAEMICS

1  Mfor  Metformin 500mg  Tablets  5x10's

2  Zenzide  Gliclazide 80mg  Tablets  2x10's

ANTI EMETICS

1  Jperidon  Domperidone 10mg  Tablets  5x10's

2  Jperidon  Domperidone 5mg/5ml  Suspension  120ml

3  Vompride  ItoprideHCl 50mg  Tablets  1x10's

ANTIVIRAL

1  Virakil  Ribavirin 200mg  Capsule  1x10's

2  Virakil  Ribavirin 400mg  Capsule  1x10's

34 | P a g e

Page 35: NEW B.P

3  Virakil  Ribavirin 600mg  Capsule  1x10's

ANTIFUNGAL

1  Fungazole  Fluconazole 150mg  Capsule  1x1's

2  Atcon  Itraconazole (Pellets) 100mg  Capsule  1x4's

3  Canditic  Fluconazole 200mg  Capsule  1x4's 

ANTIOBESITY

1  Livvel  SibutramineHCl 10mg  Capsule  1x4's

2  Livvel  SibutramineHCl 15mg  Capsule  1x4's

ANTIEPILEPTICS

1  G-Tin  Gabapentin 100mg  Capsule  1x10's

2  G-Tin  Gabapentin 300mg  Capsule  1x10's

3  G-Tin  Gabapentin 400mg  Capsule  1x10's

HYPOLIPDAEMICS

1  Cholein  Atorvastatin 10mg  Tablets  1x10's

2  Cholein  Atorvastatin 20mg  Tablets  1x10's

3  E-Zee  Ezetimibe 10mg  Tablets  1x10's

CHOLAGOGUES & HEPATIC

1  Liveright

 L-Ornithine L-Aspartate 300mg, Nicotinamide

24mg,

 Riboflavin Sodium Phosphate 0.76mg/5ml

 Syrup  60ml

35 | P a g e

Page 36: NEW B.P

Pricing

Jawa is using penetration pricing strategy but are not compromising on quality.

Place

According to the placement of JawaPharmaceutical it has covered 50% share in Punjab &

NWFP, its 30% share is in Sindh and 20% share in Balochistan.

Promotion

Jawa’s marketing strategies contribute Maximum to company's growth by achieving the set

objectives keeping in view the market opportunities timely generation of revenue,

inclusion of value added products through optimal utilization of recourses.

They arrange many conferences, seminars, lectures on various diseases, broachers, diary

and souvenir to doctors.

Market Share

As there are many competitors in the Pharmaceutical industry but the direct competitors of

JawaPharma are IrzaPharma, Drug Pharma, UnexoPharma. UnexoPharma is the market leader.

JawaPharma and IrzaPharmais market challenger and have approximately equal share.

USP

The unique selling point of Jawa Pharmaceutical is to provide best quality product to their

customers at competitive price and its Vision Statement says:-

“Committed to save Humanity”

36 | P a g e

Page 37: NEW B.P

Other Strategies

Research & Development

Jawa Pharmaceutical has an established Product Development laboratory where new form

developed under supervision of high qualified and experienced technical staff. In not only new

formulations are developed but also analytical methods for new product are developed &

validated.

Our product development lab has successfully introduced formulations in therapeutic areas

such as antibiotics &anti infective, cardiovascular preparations, analgesic, NSAIDs & newer anti-

Rheumatic such as COX-2 inhibitors, antiviral, vitamins, cholesterol lowering agents, Anti-

Anemic, anti-allergic etc.

Production

The production department has always been the back bone of the company and is a great

reason for the growth of the company. Jawa pharmaceuticals has divided its production

departments into 4 different sections that are

Tablet

Syrup

Injection

Capsuls

All the above mentioned products have different sections where these products are

produced, packed and designed. All the departments heads are accountable for their

demartments to the production director. Which overview the work activities. The

organization is using the batch production system.

Problem Section37 | P a g e

Page 38: NEW B.P

Main problem according to the Management:

Low employee morale and less interest in work.

Lack of customer loyalty.

High rate employee turn over.

Main problem acourding to our analysis:

Ceneteralized decision making system increases the time utalization.

HR department is not working propely and they are not having any specified job

discription for the emloyees and not having any pactulier HR activities.

Sub problems:

Company is not having the proper M.I.S system working.

Strategies Alterbatives

Solution to solve the problem:

The company sales force should activitely meet the customers twice in a week and

described their products benefits, assured quality at competative prices to them.

The management should allow the employees to participate activiely in decision

making process. It help the company to develop a friendly enviornment which leads

38 | P a g e

Page 39: NEW B.P

to generate the innovate ideas and helps in making proper strategies. The other

note able benefit is that employee feel comfort at work place that gradually makes

his/her interest in the work.

The company should developed a proper HR department that would generate a

efficient work force and also over come the companies other problems like incitives

and motivation technique, low employee morale and interest

IMPLIMENTING PLAN

We suggest the proper HR department i.e:-

HR VISIONThere should be a proper HR vision in the line of which company should hire dynamic and efficient employees which will definitelyhelps in increasing the growth of company. Proper training should be given to the employees to polish the skills and enhance their knowledge about the Pharmaceuticals industry.

TRAINING AND DEVELOPMENTCompanyshould encourage the employees to enhance their knowledge and skills base, and support their efforts through trainings. Their Training and Development program should outlines clear paths for professional development on either a technical or a managerial level. Meeting up with different people from different backgrounds during the training program gives exposure and broadens their horizons, resulting into new and innovative ideas. Company should ensure the employees to have the skills and leadership abilities to succeed and reach their full potential.

SALARYCompany should develop the best compensation packages with refers to the market.We suggest the following benefits and privileges for the motivation of employees to JAWA Pharmaceuticals.

Group Life Insurance

Provident fund Leave benefits Leave encashment Health Insurance (self & family) Medical Allowance

39 | P a g e

Page 40: NEW B.P

Bonus Annual gathering Transport facilities Hajj draws

RECRUITMENT AND SELECTIONJawa pharmaceuticals should recruit and select their employees only on the basis of merit. They should hire employees without any regard to race, color, religion, gender and marital status. Jawa pharmaceuticals should adopt the policy of hiring the right person for the right job, to ensure that they are operating maximum efficiency level.

40 | P a g e


Recommended